GPER1 and melanoma: Similar observations by Sun and coworkers have demonstrated that the stimulation of melanoma cells with the synthetic GPER agonist, G1, promotes the cAMP-dependent activation of the microphthalmic transcription factor (MITF), which regulates tyrosinase, a rate-limiting enzyme in melanin production [76].